William Sean Davidson

William Sean Davidson

Auto-generated profile, based on publicly available information

William Sean Davidson

Department of Pathology and Laboratory Medicine, University of Cincinnati, OH (W.S.D.).

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 1998 in Journal of Biological Chemistry
Verified
Journal Article
Open access
WDW. Sean Davidson
W. Sean Davidson
AJAna Jonas
Ana Jonas
DCDavid F. Clayton
David F. Clayton
JGJulia M. George
Julia M. George
Alpha-Synuclein is a highly conserved presynaptic protein of unknown function. A mutation in the protein has been causally linked to Parkinson's disease in humans, and the normal protein is an abundant component of the intraneuronal inclusions (Lewy bodies) characteristic of the disease. alpha-Synuclein is also the precursor to an intrinsic component of extracellular plaques in Alzheimer's disease. The alpha-synuclein sequence is largely composed of degenerate 11-residue repeats reminiscent of the amphipathic alpha-helical domains of the exchangeable apolipoproteins. We hypothesized that alpha-synuclein should associate with phospholipid bilayers and that this lipid association should stabilize an alpha-helical secondary structure in the protein. We report that alpha-synuclein binds to small unilamellar phospholipid vesicles containing acidic phospholipids, but not to vesicles with a net neutral charge. We further show that the protein associates preferentially with vesicles of smaller diameter (20-25 nm) as opposed to larger (approximately 125 nm) vesicles. Lipid binding is accompanied by an increase in alpha-helicity from 3% to approximately 80%. These observations are consistent with a role in vesicle function at the presynaptic terminal.

17 April 2012 in Circulation
Verified
Journal Article
Closed access
PDF file
RRRobert S. Rosenson
Robert S. Rosenson
HBH. Bryan Brewer
H. Bryan Brewer
WDW. Sean Davidson
W. Sean Davidson
ZFZahi A. Fayad
Zahi A. Fayad
VFValentin Fuster
Valentin Fuster
LYLaurent Yvan-Charvet
Laurent Yvan-Charvet

1 June 2009 in Arteriosclerosis, Thrombosis, and Vascular Biology
Verified
Journal Article
Closed access
PDF file
WDW. Sean Davidson
W. Sean Davidson
RSR.A. Gangani D. Silva
R.A. Gangani D. Silva
SCSandrine Chantepie
Sandrine Chantepie
WLWilliam R. Lagor
William R. Lagor
MCM. John Chapman
M. John Chapman
AKAnatol Kontush
Anatol Kontush
Objective— Recent proteomic studies have identified multiple proteins that coisolate with human HDL. We hypothesized that distinct clusters of protein components may distinguish between physicochemically-defined subpopulations of HDL particles, and that such clusters may exert specific biological function(s). Methods and Results— We investigated the distribution of proteins across 5 physicochemically-defined particle subpopulations of normolipidemic human HDL (HDL2b, 2a, 3a, 3b, 3c) fractionated by isopycnic density gradient ultracentrifugation. Liquid chromatography/electrospray mass spectrometry identified a total of 28 distinct HDL-associated proteins. Using an abundance pattern analysis of peptide counts across the HDL subfractions, these proteins could be grouped into 5 distinct classes. A more in-depth correlational network analysis suggested the existence of distinct protein clusters, particularly in the dense HDL3 particles. Levels of specific HDL proteins, primarily apoL-I, PON1, and PON3, correlated with the potent capacity of HDL3 to protect LDL from oxidation. Conclusions— These findings suggest that HDL is composed of distinct particles containing unique (apolipo)protein complements. Such subspeciation forms a potential basis for understanding the numerous observed functions of HDL. Further work using additional separation techniques will be required to define these species in more detail.

1 October 2013 in Journal of Lipid Research
Verified
Journal Article
Open access
PDF file
ASAmy S. Shah
Amy S. Shah
LTLirong Tan
Lirong Tan
JLJason Lu Long
Jason Lu Long
WDW. Sean Davidson
W. Sean Davidson
Recent applications of mass spectrometry technology have dramatically increased our understanding of the proteomic diversity of high density lipoproteins (HDL). Depending on the method of HDL isolation, upwards of 85 proteins have been identified, and the list continues to grow. In addition to proteins consistent with traditionally accepted roles in lipid transport, HDL carries surprising constituents, such as members of the complement pathway, protease inhibitors involved in hemostasis, acute-phase response proteins, immune function mediators, and even metal-binding proteins. This compositional diversity fits well with hundreds of studies demonstrating a wide functional pleiotrophy, including roles in lipid transport, oxidation, inflammation, hemostasis, and immunity. This review summarizes the progression of our understanding of HDL proteomic complexity and points out key experimental observations that reinforce the functional diversity of HDL. The possibility of specific HDL subspecies with distinct functions, the evidence supporting this concept, and some of the best examples of experimentally defined HDL subspecies are also discussed. Finally, key challenges facing the field are highlighted, particularly the need to identify and define the function of HDL subspecies to better inform attempts to pharmacologically manipulate HDL for the benefit of cardiovascular disease and possibly other maladies.

1 September 2013 in Journal of Clinical Lipidology
Verified
Journal Article
Closed access
PMPeter Paul MD
Peter Paul MD
PBPhilip J. Barter
Philip J. Barter
RRRobert S. Rosenson
Robert S. Rosenson
WBWilliam E. Boden
William E. Boden
MCM. John Chapman
M. John Chapman
DRDaniel J. Rader
Daniel J. Rader

1 December 2014
Verified
Book Chapter
Open access
PDF file
AKAnatol Kontush
Anatol Kontush
MLMats Lindahl
Mats Lindahl
MLMarie Lhomme
Marie Lhomme
LCLaura Calabresi
Laura Calabresi
MCM. John Chapman
M. John Chapman
WDW. Sean Davidson
W. Sean Davidson
A molecular understanding of high-density lipoprotein (HDL) will allow a more complete grasp of its interactions with key plasma remodelling factors and with cell-surface proteins that mediate HDL assembly and clearance. However, these particles are notoriously heterogeneous in terms of almost every physical, chemical and biological property. Furthermore, HDL particles have not lent themselves to high-resolution structural study through mainstream techniques like nuclear magnetic resonance and X-ray crystallography; investigators have therefore had to use a series of lower resolution methods to derive a general structural understanding of these enigmatic particles. This chapter reviews current knowledge of the composition, structure and heterogeneity of human plasma HDL. The multifaceted composition of the HDL proteome, the multiple major protein isoforms involving translational and posttranslational modifications, the rapidly expanding knowledge of the HDL lipidome, the highly complex world of HDL subclasses and putative models of HDL particle structure are extensively discussed. A brief history of structural studies of both plasma-derived and recombinant forms of HDL is presented with a focus on detailed structural models that have been derived from a range of techniques spanning mass spectrometry to molecular dynamics.